Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria.
Naganuma M, Nakamura N, Kunisaki R, Matsuoka K, Yamamoto S, Kawamoto A, Saito D, Kobayashi T, Nanki K, Narimatsu K, Shiga H, Esaki M, Yoshioka S, Kato S, Saruta M, Tanaka S, Yasutomi E, Yokoyama K, Moriya K, Tsuzuki Y, Ooi M, Fujiya M, Nakazawa A, Takagi T, Omori T, Tahara T, Hisamatsu T; Japanese UC Study Group. Naganuma M, et al. Among authors: omori t. J Gastroenterol. 2024 Apr;59(4):302-314. doi: 10.1007/s00535-024-02079-x. Epub 2024 Jan 26. J Gastroenterol. 2024. PMID: 38277006
Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial.
Naganuma M, Yokoyama Y, Motoya S, Watanabe K, Sawada K, Hirai F, Yamamoto T, Hanai H, Omori T, Kanai T, Hibi T; CAPTAIN study Group. Naganuma M, et al. Among authors: omori t. J Gastroenterol. 2020 Apr;55(4):390-400. doi: 10.1007/s00535-019-01651-0. Epub 2019 Dec 6. J Gastroenterol. 2020. PMID: 31811562 Clinical Trial.
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.
Matsuoka K, Yamazaki H, Nagahori M, Kobayashi T, Omori T, Mikami Y, Fujii T, Shinzaki S, Saruta M, Matsuura M, Yamamoto T, Motoya S, Hibi T, Watanabe M, Fernandez J, Fukuhara S, Hisamatsu T. Matsuoka K, et al. Among authors: omori t. J Gastroenterol. 2023 Aug;58(8):751-765. doi: 10.1007/s00535-023-02005-7. Epub 2023 Jun 23. J Gastroenterol. 2023. PMID: 37351647 Free PMC article.
Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease in Japan (SPREAD-J study).
Sakurai T, Omori T, Tanaka H, Ito T, Ando K, Yamamura T, Nanjjo S, Osawa S, Takeda T, Watanabe K, Hiraga H, Yamamoto S, Ozeki K, Tanaka S, Tajiri H, Saruta M; SPREAD-J group. Sakurai T, et al. Among authors: omori t. J Gastroenterol. 2023 Oct;58(10):1003-1014. doi: 10.1007/s00535-023-02017-3. Epub 2023 Jul 21. J Gastroenterol. 2023. PMID: 37479808 Free PMC article.
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.
Akiyama S, Yokoyama K, Yagi S, Shinzaki S, Tsuruta K, Yoshioka S, Sako M, Shimizu H, Kobayashi M, Sakurai T, Nomura K, Shibuya T, Takahara M, Hiraoka S, Sugai K, Yanai S, Yoshida A, Koroku M, Omori T, Saruta M, Matsumoto T, Okamoto R, Tsuchiya K, Fujii T. Akiyama S, et al. Among authors: omori t. Aliment Pharmacol Ther. 2024 Jun;59(11):1413-1424. doi: 10.1111/apt.17961. Epub 2024 Mar 17. Aliment Pharmacol Ther. 2024. PMID: 38494867
Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.
Matsuoka K, Yamazaki H, Nagahori M, Kobayashi T, Omori T, Mikami Y, Fujii T, Shinzaki S, Saruta M, Matsuura M, Yamamoto T, Motoya S, Hibi T, Watanabe M, Fernandez J, Fukuhara S, Hisamatsu T. Matsuoka K, et al. Among authors: omori t. J Gastroenterol. 2024 Jul;59(7):644-646. doi: 10.1007/s00535-024-02116-9. J Gastroenterol. 2024. PMID: 38814336 Free PMC article. No abstract available.
990 results